Insights Into Myelofibrosis (MF)

Perspectives on drivers in treatment decisions in the management of myelofibrosis (MF)

Gulf #1 – January 12, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center

Midwest #1 – January 18, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio

Northeast #1 – January 19, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Midwest #2 – January 25, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio

Northeast #2 – January 26, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Northeast #3 – February 2, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Ohio Valley – February 9, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital

West #2 – February 16, 2022

Faculty Chair

Srdan Verstovsek, MD, PhD

MD Anderson Cancer Center

West #3 – February 23, 2022

Faculty Chair

Srdan Verstovsek, MD, PhD

MD Anderson Cancer Center

Ohio Valley #2 – March 9, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital

Midwest #3 – March 15, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio

Ohio Valley #3 – March 30, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital

Gulf #2 – April 6, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center

Gulf #3 – April 13, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center

Mid-Atlantic #1 – April 20, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Mid-Atlantic #2 – May 4, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • West region

More Information

  • Virtual series
  • West region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Mid-Atlantic region

Example Agenda

Export meeting topics

View Agenda

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of MF
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained
    • Current management and emerging challenges in MF
    • Current therapy paradigms for MF
    • Unmet needs and emerging paradigms

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors will comprise 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.